Misplaced Pages

Talk:Beta blocker: Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively← Previous editNext edit →Content deleted Content addedVisualWikitext
Revision as of 03:49, 22 April 2017 editJytdog (talk | contribs)Autopatrolled, Extended confirmed users, Pending changes reviewers, Rollbackers187,951 edits fix 2← Previous edit Revision as of 21:27, 30 April 2017 edit undoBiochemistry&Love (talk | contribs)Extended confirmed users, New page reviewers5,950 edits →Unsourced: Added some info from a chart on Pharmacist's Letter (now "Therapeutic Research Center").Next edit →
Line 22: Line 22:


;Nonselective agents ;Nonselective agents
*]<ref name="PharmLetter BB Table">{{cite web|title=Comparison of Oral Beta-Blockers|url=https://pharmacist.therapeuticresearch.com/Content/Segments/PRL/2012/Dec/Comparison-of-Oral-Beta-Blockers-5052|website=pharmacist.therapeuticresearch.com|publisher=Therapeutic Research Center|accessdate=30 April 2017}}</ref>
*]
*] (has additional α-blocking activity)<ref>{{cite journal |vauthors=Rosendorff C |title=Beta-blocking agents with vasodilator activity |journal=Journal of Hypertension. Supplement |volume=11 |issue=4 |pages=S37–40 |year=1993 |pmid=8104240 |doi=10.1097/00004872-199306003-00009}}</ref> *] (has additional α1-blocking activity)<ref>{{cite journal |vauthors=Rosendorff C |title=Beta-blocking agents with vasodilator activity |journal=Journal of Hypertension. Supplement |volume=11 |issue=4 |pages=S37–40 |year=1993 |pmid=8104240 |doi=10.1097/00004872-199306003-00009}}</ref>
*] *]
*] (has additional α1-blocking activity)<ref name="PharmLetter BB Table" />
*]
*] (has additional α1-blocking activity)<ref name="PharmLetter BB Table" />
*]
*] *]<ref name="PharmLetter BB Table" />
*] *]
*] (has intrinsic sympathomimetic activity)<ref name="PharmLetter BB Table" />
*]
*] (has intrinsic sympathomimetic activity)<ref name="PharmLetter BB Table" />
*]
*] (not considered a "typical beta-blocker")<ref name="PharmLetter BB Table" />
*]
*] *]<ref name="PharmLetter BB Table" />


;β<sub>1</sub>-selective agents ;β<sub>1</sub>-selective agents
Also known as cardioselective Also known as cardioselective
*] (has intrinsic sympathomimetic activity, ISA)<ref name="PharmLetter BB Table" />
*]
*] *]<ref name="PharmLetter BB Table" />
*] *]<ref name="PharmLetter BB Table" />
*] *]<ref name="PharmLetter BB Table" />
*] *]
*] *]<ref name="PharmLetter BB Table" />
*] *]<ref name="PharmLetter BB Table" />


;β<sub>2</sub>-selective agents ;β<sub>2</sub>-selective agents
Line 61: Line 61:
**Acebutolol, ] **Acebutolol, ]


;ndication differences ;Indication differences
*Agents specifically indicated for cardiac arrhythmia *Agents specifically indicated for cardiac arrhythmia
**], ], ] **], ], ]

Revision as of 21:27, 30 April 2017

Ideal sources for Misplaced Pages's health content are defined in the guideline Misplaced Pages:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Beta blocker.
This is the talk page for discussing improvements to the Beta blocker article.
This is not a forum for general discussion of the article's subject.
Article policies
Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL
Archives: 1Auto-archiving period: 2 months 
WikiProject iconPharmacology C‑class Top‑importance
WikiProject iconThis article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Misplaced Pages. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology
CThis article has been rated as C-class on Misplaced Pages's content assessment scale.
TopThis article has been rated as Top-importance on the project's importance scale.


Unsourced

Moved here per WP:PRESERVE as this is almost all unsourced. Per WP:BURDEN please do not restore without finding reliable sources, checking the content against them, and citing the sources.

Examples
Dichloroisoprenaline, the first beta blocker
Nonselective agents
β1-selective agents

Also known as cardioselective

β2-selective agents
β3-selective agents
Comparative information
Pharmacological differences
  • Agents with intrinsic sympathomimetic action (ISA)
    • Acebutolol, carteolol, celiprolol, mepindolol, oxprenolol, pindolol
  • Agents with greater aqueous solubility (hydrophilic beta blockers)
    • Atenolol, celiprolol, nadolol, sotalol
  • Agents with membrane stabilizing effect
Indication differences

Propranolol is the only agent indicated for control of tremor, portal hypertension, and esophageal variceal bleeding, and used in conjunction with α-blocker therapy in phaeochromocytoma.

References

  1. ^ "Comparison of Oral Beta-Blockers". pharmacist.therapeuticresearch.com. Therapeutic Research Center. Retrieved 30 April 2017.
  2. Rosendorff C (1993). "Beta-blocking agents with vasodilator activity". Journal of Hypertension. Supplement. 11 (4): S37–40. doi:10.1097/00004872-199306003-00009. PMID 8104240.
  3. Cite error: The named reference Rossi was invoked but never defined (see the help page).
Categories: